UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the quarterly period ended
For the transition period from ________________to ________________
(Name of small business issuer in its charter)
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
TradewindsUniversal.com
(Address and telephone number of registrant's principal executive offices and principal place of business)
Check
whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was
required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
☐ | Accelerated filer | ☐ |
|
|
☒ | Smaller reporting company | |
| Emerging growth company | |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐
No
Securities registered pursuant to Section 12(b) of the Act: None
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
| Class | November 14, 2024 |
| Common Stock, $0.001 par value per share |
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This document contains certain statements of a forward-looking nature. Such forward-looking statements, including but not limited to statements regarding projected growth, trends and strategies, future operating and financial results, financial expectations, and current business indicators, are based upon current information and expectations and are subject to change based on factors beyond the control of the Company. Forward-looking statements typically are identified by the use of terms such as “look,” “may,” “should,” “might,” “believe,” “plan,” “expect,” “anticipate,” “estimate,” and similar words, although some forward-looking statements are expressed differently. The accuracy of such statements may be impacted by a number of risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including but not limited to those set forth herein and in our Annual Report on Form 10-Q.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as federal securities laws require, we undertake no obligation to update forward-looking information. Nonetheless, the Company reserves the right to make such updates from time to time by press release, periodic report or other method of public disclosure without the need for specific reference to this Report. No such update shall be deemed to indicate that other statements not addressed by such update remain correct or create an obligation to provide any other updates.
TABLE OF CONTENTS
INDEX
| Part I. | Financial Information | |
| Item 1. | Financial Statements | 1 |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 8 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 12 |
| Item 4. | Controls and Procedures | 12 |
| Part II. | Other Information | |
| Item 1. | Legal Proceedings | 13 |
| Item 1A. | Risk Factors | 13 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 13 |
| Item 3. | Defaults upon Senior Securities | 13 |
| Item 4. | Mining Safety Disclosures | 13 |
| Item 5. | Other Information | 13 |
| Item 6. | Exhibits | 13 |
| Signatures | 14 |
i
Financial Statements
Tradewinds Universal
Table of Contents
September 30, 2024
| 1 |
TRADEWINDS UNIVERSAL
BALANCE SHEETS
| September 30, 2024 (Unaudited) | December 31, 2023 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $ | $ | ||||||
| Deferred Tax Asset | ||||||||
| Inventory | ||||||||
| Prepaid Expense | ||||||||
| Total Current Assets | ||||||||
| Intangible Assets | ||||||||
| Total Assets | $ | $ | ||||||
| Liabilities and Stockholders' Equity | ||||||||
| Current Liabilities | $ | — | $ | — | ||||
| Total Current Liabilities | ||||||||
| Total Liabilities | ||||||||
| Commitments and Contingencies (Note 3) | ||||||||
| Stockholders' Equity | ||||||||
| Common stock, $ par value, shares authorized, issued and outstanding | ||||||||
| Additional Paid in Capital | ||||||||
| Accumulated Deficit | ( | ) | ( | ) | ||||
| Total Stockholders' Equity | ||||||||
| Total Liabilities and Stockholders' Equity | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited financial statements
| 2 |
TRADEWINDS UNIVERSAL
STATEMENTS OF OPERATIONS
(Unaudited)
| For the Three Months ended September 30, 2024 | For the Three Months ended September 30, 2023 | For the Nine Months ended September 30, 2024 | For the Nine Months ended September 30, 2023 | |||||||||||||
| Revenue | ||||||||||||||||
| Commission Income | $ | $ | $ | $ | ||||||||||||
| Distribution Rights | ||||||||||||||||
| Product Sales | ||||||||||||||||
| Total Sales | ||||||||||||||||
| Cost of Sales | ||||||||||||||||
| Gross Profit | ||||||||||||||||
| Operating Expenses | ||||||||||||||||
| Professional Fees | ||||||||||||||||
| Consulting | ||||||||||||||||
| Marketing | ||||||||||||||||
| General and Administrative | ||||||||||||||||
| Total Operating Expenses | ||||||||||||||||
| Net Loss Before Taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Provision for Income Tax | ( | ) | ||||||||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net Loss Per share - Basic and Diluted | $ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Basic and diluted weighted average shares used in the calculation of net income per common share | ||||||||||||||||
The accompanying notes are an integral part of these unaudited financial statements.
| 3 |
TRADEWINDS UNIVERSAL
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023
(Unaudited)
| Common Stock | Common Stock Amount | Additional Paid-in Capital | Accumulated Deficit | Total Stockholders’ Equity | ||||||||||||||||
| Balance at December 31, 2022 | $ | $ | $ | $ | ||||||||||||||||
| Stock Issued for Cash | ||||||||||||||||||||
| Net Loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance March 31, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Net Income | — | |||||||||||||||||||
| Balance June 30, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Stock Issued for Cash | ||||||||||||||||||||
| Net Loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance September 30, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Common Stock | Common Stock Amount | Additional Paid-in Capital | Accumulated Deficit | Total Stockholders’ Equity | ||||||||||||||||
| Balance at December 31, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Net Loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance March 31, 2024 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Net Loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance June 30, 2024 | $ | $ | ( | ) | $ | |||||||||||||||
| Net Loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance September 30, 2024 | $ | $ | $ | ( | ) | $ | ||||||||||||||
The accompanying notes are an integral part of these unaudited financial statements
| 4 |
TRADEWINDS UNIVERSAL
STATEMENTS OF CASH FLOW
(Unaudited)
| For the Nine Months ended September 30, 2024 | For the Nine Months ended September 30, 2023 | |||||||
| Operating Activities | ||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to Reconcile Net Loss to Net Cash from Operating Activities | ||||||||
| Deferred Taxes | ||||||||
| Changes in Operating Assets and Liabilities | ||||||||
| Inventory | ||||||||
| Prepaid Expense | ( | ) | ||||||
| Taxes Payable | ( | ) | ||||||
| Deferred Revenue | ( | ) | ||||||
| Net Cash from Operating Activities | ( | ) | ( | ) | ||||
| Investing Activities | ||||||||
| Purchase of Intangible Asset | ( | ) | ||||||
| Net Cash from Investing Activities | ( | ) | ||||||
| Financing Activities | ||||||||
| Stock Issued for Cash | ||||||||
| Net Cash from Financing Activities | ||||||||
| Net Change in Cash and Cash Equivalents | ( | ) | ( | ) | ||||
| Cash and Cash Equivalents at Beginning of Period | ||||||||
| Cash and Cash Equivalents at End of Period | $ | $ | ||||||
| Supplemental Cash Flow Information | ||||||||
| Cash Paid for Interest | $ | $ | ||||||
| Cash Paid for Taxes | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited financial statements
| 5 |
TRADEWINDS UNIVERSAL
NOTES TO THE UNAUDITED FINANCIAL STATEMENTS
September 30, 2024
Note 1 – Nature of Operations
Nature of Operations
Tradewinds Universal (“Tradewinds” or the “Company”) was incorporated in Wyoming on December 21, 2021, for the purpose of developing, manufacturing, and distributing high nutrient-based edible insect protein bars, shakes, and other high-nutrition foods/ snacks and drinks.
Additionally, on December 7, 2022, Tradewinds acquired a pain relief formula for dogs, which it intends to manufacture and distribute in the form of treats.
Note 2 - Summary of Significant Accounting Policies
Basis of Presentation
The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company.
Estimates
The preparation of the financial statement in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts. Accordingly, actual results could differ from those estimates.
Cash And Cash Equivalents
The Company maintains a cash balance in
a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows,
all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. There were
Inventory
Inventory is recorded at lower of cost or market; cost is computed on a first-in first-out basis.
Intangible Asset
As of September 30, 2024 and December 31,
2023, the Company had an intangible asset of $
Impairment Of Long-Lived Assets
The Company reviews its long-lived assets for impairment in
accordance with Accounting Standards Codification ("ASC") 360-10, Impairment or Disposal of Long-Lived Assets. The Company
evaluates long-lived assets, such as depreciable intangible assets for impairment whenever events or changes in circumstances indicate
that the carrying value of an asset may not be recoverable. Indefinite lived intangible assets are tested for impairment at least annually.
If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying
value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash
flow approach or, when available and appropriate, to comparable market values. There were
Revenue Recognition
The Company recognizes revenue in accordance with ASC 606. Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five-step model in order to determine this amount:
| • | Identification of the promised goods in the contract; | |
| • | Determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; | |
| • | Measurement of the transaction price, including the constraint of variable consideration; | |
| • | Allocation of the transaction price of the performance obligations; | |
| • | Recognition of revenue when (or as) the Company satisfies each performance obligation. |
The performance obligation associated with a typical product sale will be satisfied upon delivery to customers, and the revenue will be recognized at that time. Payments are due on demand. The Company does not offer any warranty on its products; however, customers do receive a manufacturer’s warranty.
The Company's main revenue stream to date has been from the sale of distribution territories for its protein bars. The Company sells rights to distribute its protein bars and other products to outside parties and determines if the distribution agreement (“DA”) is a distinct (separate) performance obligation in accordance with ASC 606. If the DA is determined not to be distinct, the license is combined with the other goods or services and the combined performance obligation is accounted for using the general revenue recognition model outlined above. If the DA is determined to be distinct, the Company analyzes whether the DA is functional or symbolic to assess the timing of revenue recognition. The DA by the Company was determined to be a distinct performance obligation of symbolic intellectual property (“IP)”, which provides a right to access IP. ASC 606 states that revenue from licenses of IP deemed to provide a right to use IP will be recognized at a point in time when control is transferred.
In accordance with Topic 606, the Company analyzes the following to determine when to recognize DA revenue:
| i. | Whether the transaction represents a sale or licensing of IP |
| ii. | Whether the IP is a distinct performance obligation, |
| iii. | The nature of the license - functional or symbolic; and |
| iv. | The timing of recognition based on the nature of the license. |
The Company only applies the five-step model to contracts when it is probable the entity will collect the consideration it is entitled to in exchange for the goods and represents services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligations when the performance obligation is satisfied or as it is satisfied. The Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligations when the performance obligation is satisfied or as it is satisfied. Generally, the Company's performance obligations are transferred to customers at a point in time, typically upon delivery.
| 6 |
Fair Value of Financial Instruments
ASC 825, Financial Instruments requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable, and accrued liabilities, when reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities, and equity instruments of the Company are either recognized or disclosed in the financial statements, together with other information relevant to making a reasonable assessment of future cash flows, interest rate risk, and credit risk. Where practicable, the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise, only available information pertinent to fair value has been disclosed. The Company follows ASC 820, Fair Value Measurements and ASC 825, which permits entities to choose to measure many financial instruments and certain other items at fair value.
Income Taxes
In accordance with ASC 740 Income Taxes, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in Income in the period that includes the enactment date.
The Company has adopted the provisions set
forth in ASC 740 to account for uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions,
the Company asserts certain tax positions based on its understanding and interpretation of the income tax law. The taxing authorities
may challenge such positions, and the resolution of such matters could result in recognition of Income tax expense in the Company's financial
statements. Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns. The Company
uses the "more likely than not" criterion for recognizing the tax benefit of uncertain tax positions and to establish measurement
criteria for income tax benefits. The Company' s policy is to recognize interest and/or penalties related to income tax matters in income
tax expense. The Company had
The Company computes income (loss) per share in accordance with ASC 260 Earning Per Share, which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. The Company does not have a complex capital structure requiring the computation of diluted earnings per share.
Recently Issued Accounting Pronouncements
There have been no recent accounting pronouncements or changes in accounting pronouncements during the nine months ended September 30, 2024 that are of significance or potential significance to the Company.
Note-3 - Commitments and Contingencies
During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with ASC 450, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of September 30, 2024, and December 31, 2023, the Company is not aware of any contingent liabilities that should be reflected in the unaudited financial statements.
Note 4 - Income Taxes
The Company recognizes deferred income tax liabilities and assets for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.
The components
of the Company's reconciliation of income taxes computed at the statutory rate of
September 30, 2024 | December 31, 2023 | |||||||
| Net Loss Before Taxes | $ | ( | ) | $ | ( | ) | ||
| Effective Tax Rate | % | % | ||||||
| Provision For Income Taxes | $ | ( | ) | $ | ( | ) | ||
September 30, 2024 | December 31, 2023 | |||||||
| Deferred tax asset | $ | $ | ||||||
| Less valuation allowance | ( | ) | ||||||
| Net deferred tax asset | $ | $ | ||||||
As of September 30, 2024, the components of the deferred tax asset related to net loss. Due to uncertainties surrounding the Company’s ability to generate future U.S. taxable income to realize these assets, a full valuation allowance has been established to offset the net U.S. deferred tax asset as of September 30, 2024.
Note 5 - Subsequent Events
In accordance with ASC 855, Subsequent Events, the Company has analyzed its operations subsequent to September 30, 2024 to the date the unaudited financial statements were issued and has determined that it does not have any material subsequent events to disclose.
| 7 |
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes to those statements included elsewhere in this prospectus. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including, but not limited to, those discussed under the section titled “Risk Factors” and elsewhere in this prospectus. See the section titled “Special Note Regarding Forward-Looking Statements” elsewhere in this prospectus.
Overview
We specialize in the development, manufacturing, and distribution of nutrient-rich foods, setting ourselves apart by integrating insect-based proteins into our products. Our primary business product line is marketed under the brand Universal Proteins (UP). Our current product line is based on protein bars. The Company has plans for a secondary business focus to include pet foods, with a particular emphasis on developing, manufacturing, and distributing dog treats designed to alleviate pain.
In early 2022, we began formulating recipes using insect protein powder derived from crickets. Our CEO, Andrew Read, in collaboration with a nutritionist, formulated two different recipes for the preparation of the first protein bars. During this process we narrowed our primary protein source to cricket (Orthoptera) powder from ENTOMO FARMS, a Canadian Company that has supplied protein powder from crickets for over 10 years.
Following the initial development of our first bars, we conducted a taste test to finalize the ingredients. Subsequently, we initiated the process of partnering with a copacker/manufacturer. In March 2022, we visited the YouBar facility in Los Angeles, California, and enlisted their expertise to consult on and develop our initial two bars, also referred to as SKUs: Chocolate Almond and Peanut Butter and Fruit. YouBar has developed and manufactured protein bars since 2006 for companies whose bars are sold in well-known retail establishments such as Whole Foods, Trader Joe's, Costco, Target, Amazon, and GNS, according to their website www.youbars.com.
The R&D collaboration with YouBar spanned almost a year to develop the first two flavors (SKUs). This comprehensive process involved testing various ingredient combinations for optimal taste, experimenting with baking or rolling techniques for the bars, and refining the product to facilitate mass production. Youbar sourced material for additional bar ingredients, such as: fruits, and flavors, all of which received subsequent approval by the Company.
Following the approval process, we progressed to the packaging development and manufacturing phase, which lasted approximately nine months. Tradewinds was selective in the type of products and service providers it used for each aspect of packaging. Manufacturing and packaging of the two formulated SKUs were completed and shipped on December 4, 2023, at which time we received the first order, which included 10,848 peanut butter fruit bars and 10,764 chocolate almond bars. We have initiated online marketing and sales of the UP-protein bars; however, our main focus has been directed toward larger retail outlets and distributors such as Trader Joe’s, Costco, and Coremark. We anticipate that it may take an uncertain amount of time to secure a sales order from larger retailers, if it happens at all. In April of 2024 we entered into a purchase agreement with a smaller distributor for 1,040 cases of UP bars containing 12,480 bars for $24,960. At September 30, 2024, all bars in inventory had been sold.
Raw materials used in the protein bars are generic to energy\protein bars sourced by Youbar. The availability of ingredients is subject to standard supply and demand for energy bars. Protein Cricket Powder protein is purchased from Entomo Farms, a Company based out of Canada that has supplied protein powder from crickets for over 10 years. All ingredients required for the manufacturing of the bars are currently abundant.
Our UP Protein Bars are currently available for purchase on our website, UPProteins.com. We have initiated a marketing program directed at retail outlets using social media platforms, as mentioned in our Business Description on Page 12. We anticipate the completion of one more new SKUs for a bar by the end of the year 2024. The Company has plans for a secondary business focus to include pet foods and has acquired a formula for developing, manufacturing, and distributing dog treats to alleviate pain. In addition, we plan to continue to market Distribution Rights to various territories. We also plan to continue to market the licensing rights for our formula for pain relief for dogs. However, there is no assurance that licensing rights or products can be sold sufficiently to assist with our operational plan. We anticipate raising capital through revenues from the sale of licensing rights or some form of debt or equity financing. At this time, we have no arrangements for any funding source.
We expect our operating expenses to significantly increase as we continue to develop additional product lines and establish a market for our current product line. We also expect to incur additional operating expenses as we begin operating as a public company. Our net losses may fluctuate significantly from quarter to quarter and year to year, depending on the timing and scope of our marketing and our expenditures on other research and development activities.
| 8 |
Results of Operations
Comparison of the Three Months and Nine Months Ended September 30, 2024 and 2023
Revenue
For the nine months ended September 30, 2024
For the period ended September 30, 2024, the Company had total sales of $146,179. The increase in revenues was directly related to the sales of commissions from affiliate marketing and sales of the Company's UP protein bars.
For the nine months ended September 30, 2023
For the period ended September 30, 2023, the Company had total sales of $90,602. Revenues were related to the sales of commissions from affiliate marketing as well as the sale of distribution rights for the UP Protein bars. The Company was in the process of finalizing formulations for its protein bars and had not yet begun sales.
For the three months ended September 30, 2024
For the period ended September 30, 2024, the Company had total sales of $28,068. The decrease in revenues was directly related to the decrease in sales of commissions from affiliate marketing and sales of the Company's UP protein bars.
For the three months ended September 30, 2023
For the period ended September 30, 2023, the Company had total sales of $41,750. Revenues were directly related to the sales of commissions from affiliate marketing. The Company was in process of finalizing formulations for its protein bars and had not yet begun sales.
Cost of Goods Sold
For the nine months ended September 30, 2024
For the period ended September 30, 2024, the Company had cost of sales of $21,645. The increase was directly related to the sales of the Company's UP protein bars.
For the nine months ended September 30, 2023
For the period ended September 30, 2023, the Company had cost of sales of $13,022 as its UP- Protein bars were still being designed and formulated.
| 9 |
For the three months ended September 30, 2024
For the period ended September 30, 2024, the Company had cost of sales of $9,132. The decrease was directly related to the sales of the Company's UP protein bars.
For the three months ended September 30, 2023
For the period ended September 30, 2023, the Company had cost of sales of $13,022 as its UP Protein bars were still being designed and formulated.
Gross Profit
For the nine months ended September 30, 2024
For the period ended September 30, 2024, the Company had a gross profit of $124,534. The increase from the same period in the previous year was directly related to the sales of the Company's UP protein bars and the increase of sales of commissions from affiliate marketing.
For the nine months ended September 30, 2023
For the period ended September 30, 2023, the Company had a gross profit of $77,580. The gross profit was less than the same period of 2024 as its UP Protein bars were still being designed and formulated, and its sales of commissions from affiliate marketing program was just beginning.
For the three months ended September 30, 2024
For the period ending September 30, 2024, the Company had a gross profit of $18,936. The decrease from the same period in the previous year was directly related to the sales of the Company's UP protein bars and the decrease of sales of commissions from affiliate marketing.
For the three months ended September 30, 2023
For the period ended September 30, 2023, the Company had a gross profit of $28,727. The gross profit was more than the same period of 2024 as its UP- Protein bars were still being designed and formulated, and its sales of commissions from the affiliate marketing program were in its initial stages of development.
Operating Expenses
For the nine months ended September 30, 2024
For the period ended September 30, 2024, the Company had operating expenses of $180,413. We had $43,493 in professional fees which increased related to our registration statement filings. We had an increase in marketing fees, which were $129,657, attributed to the startup marketing for our UP Protein bars. We had $3,050 in consulting fees, a decrease due to our marketing program. We had $4,213 in general and administrative costs related to the expansion of our business.
For the nine months ended September 30, 2023
For the period ended September 30, 2023, the Company had operating expenses of $107,591. We had $6,784 in professional fees which related to our filings of our registration statement. We had marketing fees of $2,943 attributed to the startup marketing for our UP Protein bars. We had $94,200 in consulting fees due to our marketing program and fees related to the preparation of our registration statement. We had $3,664 in general and administrative costs.
| 10 |
For the three months ended September 30, 2024
For the period ended September 30, 2024, the Company had operating expenses of $55,483. We had $22,168 in professional fees which increased related to our filings of our registration statement. We had an increase in marketing fees which were $31,918, attributed to the startup marketing for our UP Protein bars. We had $1,050 in consulting fees. Consultants are engaged on an as-needed basis. The decline in consulting fees for the period was due to the lack of demand. We had $347 in general and administrative costs related to the expansion of our business.
For the three months ended September 30, 2023
For the period ended September 30, 2023, the Company had operating expenses of $41,398. We had $ 0 in professional fees. We had marketing fees which were $0, as we hadn't started our marketing programs yet. We had $39,500 in consulting fees. We had $1,898 in general and administrative costs related to operations of our business.
Net Loss
For the nine months ended September 30, 2024
For the period ended September 30, 2024, the Company had a net loss of $(55,879). Although our gross profit had increased to $124,534, we had operating expenses of $180,413. Both our gross profit and expense increases were directly related to the sales of the Company's UP protein bars and the increase of sales of commissions from affiliate marketing. In addition, we had a deferred tax asset of $58,106 resulting in a valuation allowance of $(58,106).
For the nine months ended September 30, 2023
For the period ended September 30, 2023, the Company had a net loss of $27,952. Although our gross profit totaled to $77,580, we had operating expenses of $107,591. Our gross profit and expenses were directly related to the initial startup of the Company's UP protein bars and the sales of commissions from affiliate marketing.
For the three months ended September 30, 2024
For the period ended September 30, 2024-, the Company had a net loss of $28,872. Our gross profit had decreased to $18,936 and we had operating expenses of $55,483. Both our gross profit and expenses were directly related to the decrease in sales of the Company's UP protein bars and the increase of sales of commissions from affiliate marketing.
For the three months ended September 30, 2023
For the period ended September 30, 2023, the Company had a net loss of $10,612. Our gross profit was $28,727 and we had operating expenses of $41,398. We had less expenses during the period as we had not yet begun directing resources toward our registration statement or marketing. Both our gross profit and expenses were directly related to sales of commissions from affiliate marketing.
Liquidity and Capital Resources
As of September 30, 2024, we had cash and cash equivalents of $3,903. To date, we have financed our operations primarily through revenue generated from operations, private placements of our securities and advances from our founder.
Management has prepared estimates of operations and believes it will have sufficient funds to fund our operations and to service our debt obligations for at least the next twelve months. We may, however, in the future require additional cash resources due to changing business conditions, implementation of our strategy to expand our business, or other investments or acquisitions we may decide to pursue. If our own financial resources are insufficient to satisfy our capital requirements, we may seek to sell additional equity or debt securities or obtain additional credit facilities. The sale of additional equity securities could result in dilution to our stockholders. The incurrence of indebtedness would result in increased debt service obligations and could require us to agree to operating and financial covenants that would restrict our operations. Financing may not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable to us, or at all, could limit our ability to expand our business operations and could harm our overall business prospects.
The accompanying financial statements have been prepared on a going concern basis under which we are expected to be able to realize our assets and satisfy our liabilities in the normal course of business.
| 11 |
For the nine months ended September 30, 2024, compared to September 30, 2023
The change in stockholders' equity at September 30, 2024, was primarily attributable to operating losses incurred in the period. In the fourth quarter of 2023 22,000,000 shares were issued to our President which was the primary reason for the change. During the nine month period ended September 30, 2024, we used $24,310 in operating activities compared to $68,763 used in operating activities during September 30, 2023.
Investing Activities
For September 30, 2024, we had no investing activities and for September 30, 2023 we used $1,500 in investing activities for an intangible asset for website development.
Financing Activities
Our financing activities generally consist of the proceeds from the sale of our common stock. During September 30, 2024, we had $0 in financing activity, and September 30, 2023 we had $22,000 in financing activities from the issuance of stock.
The Company believes it has insufficient cash resources available to fund its primary operation. The Company has no, current, off-balance sheet arrangements and does not anticipate entering into any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition. The Company has no agreements in place with its shareholders, officer and director or with any third parties to fund operations beyond the end of the Company's 4th quarter. The Company has not negotiated nor has available to it any other third-party sources of liquidity.
Off Balance Sheet Items
We do not have any off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as “special purpose entities” (SPEs).
Significant Accounting Policies and Estimates
Management's Discussion and Analysis of Financial Condition and Results of Operations discusses the Company's financial statements which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experiences and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
An evaluation was performed under the supervision of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial and accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by our Annual Report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, as of September 30,2024, our disclosure controls and procedures were not effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms due to material weaknesses in our internal controls as described in the December 31, 2023 annual report.
Changes in Internal Control Over Financial Reporting.
We have made no change in our internal control over financial reporting during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
| 12 |
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The Company was not subject to any legal proceedings during the three-month and nine-month periods ended September 30, 2024 or year ended December 31, 2023 and to the best of our knowledge and belief no proceedings are currently threatened or pending.
Item 1A. Risk Factors
As a "smaller reporting company" as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults upon Senior Securities
None.
Item 4. Mining Safety Disclosures
Not applicable to our Company.
Item 5. Other Information
During
the quarter ended September 30, 2024, no director or officer of the Company
Item 6. Exhibits
** Filed Herewith
| 13 |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized
| Dated: November 14, 2024 | TRADEWINDS UNIVERSAL | |
| By: | /s/ Andrew Read | |
| Andrew Read, | ||
| Chief Executive Officer | ||
| 14 |